Sunday review: GlaxoSmithKline, Elliott Management and Caxton Associates
Chums at the Mail on Sunday dug out a decent tale about top institutional shareholders backing GlaxoSmithKline in its running battle with American hedgie Elliott Management.
Date:Sunday, 16 May 2021 5:10 pm
